Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl J Lackner

Showing results (11-20 of 437) with videos related to

Pageof 44
Sort By:
Clinical Chemistry and Laboratory Medicine|November 15, 2022
Cardiac troponins - a paradigm for diagnostic biomarker identification and developmentKarl J Lackner
Clinical Chemistry and Laboratory Medicine|September 14, 2017
High-sensitivity assays for cardiac troponins - continuedKarl J Lackner
Clinical Chemistry and Laboratory Medicine|March 15, 2019
Cardiac biomarkers - 2019Karl J Lackner
Clinical Chemistry and Laboratory Medicine|December 14, 2006
Initiation and progression of atherosclerosis--enzymatic or oxidative modification of low-density lipoprotein?Michael Torzewski, Karl J Lackner
Italian Heart Journal : Official Journal of the Italian Federation of Cardiology|May 4, 2004
Atherosclerosis, oxidative stress and glutathione peroxidase-1: a new kid on the blockKarl J Lackner, Stefan Blankenberg
Clinical Chemistry and Laboratory Medicine|May 17, 2018
The Theranos saga and the consequencesKarl J Lackner, Mario Plebani
The New England Journal of Medicine|March 19, 2010
Dabigatran versus warfarin for venous thromboembolismDirk Peetz, Karl J Lackner
The New England Journal of Medicine|September 28, 2018
Diagnosis and Management of the Antiphospholipid SyndromeKarl J Lackner, Nadine Müller‑Calleja
Annals of the Rheumatic Diseases|June 28, 2018
Response to: 'Protective effects of antimalarials in Chinese patients with systemic lupus erythematosus' by Wang <i>et al</i>Nadine Müller-Calleja, Karl J Lackner
Antibodies (Basel, Switzerland)|September 28, 2019
Antiphospholipid Antibodies: Their Origin and DevelopmentKarl J Lackner, Nadine Müller-Calleja
Pageof 44

Showing results (11-20 of 437) with videos related to

Sort By:
Pageof 44
Clinical Chemistry and Laboratory Medicine|November 15, 2022
Cardiac troponins - a paradigm for diagnostic biomarker identification and developmentKarl J Lackner
Clinical Chemistry and Laboratory Medicine|September 14, 2017
High-sensitivity assays for cardiac troponins - continuedKarl J Lackner
Clinical Chemistry and Laboratory Medicine|March 15, 2019
Cardiac biomarkers - 2019Karl J Lackner
Clinical Chemistry and Laboratory Medicine|December 14, 2006
Initiation and progression of atherosclerosis--enzymatic or oxidative modification of low-density lipoprotein?Michael Torzewski, Karl J Lackner
Italian Heart Journal : Official Journal of the Italian Federation of Cardiology|May 4, 2004
Atherosclerosis, oxidative stress and glutathione peroxidase-1: a new kid on the blockKarl J Lackner, Stefan Blankenberg
Clinical Chemistry and Laboratory Medicine|May 17, 2018
The Theranos saga and the consequencesKarl J Lackner, Mario Plebani
The New England Journal of Medicine|March 19, 2010
Dabigatran versus warfarin for venous thromboembolismDirk Peetz, Karl J Lackner
The New England Journal of Medicine|September 28, 2018
Diagnosis and Management of the Antiphospholipid SyndromeKarl J Lackner, Nadine Müller‑Calleja
Annals of the Rheumatic Diseases|June 28, 2018
Response to: 'Protective effects of antimalarials in Chinese patients with systemic lupus erythematosus' by Wang <i>et al</i>Nadine Müller-Calleja, Karl J Lackner
Antibodies (Basel, Switzerland)|September 28, 2019
Antiphospholipid Antibodies: Their Origin and DevelopmentKarl J Lackner, Nadine Müller-Calleja
Pageof 44